|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00595907 |
|
Date of registration:
|
07/01/2008 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis
|
|
Scientific title:
|
Observational Study of Production of IFN-Gamma by Peripheral Lymphocytes in Response to Specific Antigens Before and After Treatment for Tuberculosis |
|
Date of first enrolment:
|
October 2004 |
|
Target sample size:
|
89 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00595907 |
|
Study type:
|
Observational |
|
Study design:
|
Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Switzerland
| | | | | | | |
|
Contacts
|
|
Name:
|
Jean-Paul Janssens, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Geneva University Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- culture proven tuberculosis
Exclusion Criteria:
- age < 18
- prior tuberculosis
- HIV infection
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Tuberculosis
|
|
Primary Outcome(s)
|
|
Interferon gamma response to M. tuberculosis antigens by peripheral lymphocytes after treatment for tuberculosis
[Time Frame: 12-18 months]
|
|
Secondary ID(s)
|
|
Janssens1/2008
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|